{"id":"W3030843870","doi":"10.1200/jco.2020.38.15_suppl.7554","title":"Clinical benefit of luspatercept in patients (pts) with lower-risk MDS (LR-MDS) and high transfusion burden in the phase III MEDALIST study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Anemia; Population; Internal medicine; Randomization; Placebo; Clinical trial; Myelodysplastic syndromes; Refractory (planetary science); Phases of clinical research; International Prognostic Scoring System; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426066,0.0008611886,0.00129339,0.0002834352,0.0002502464,0.0009733388,0.0004502628,0.0007349472,0.004560478],"category_scores_gemma":[0.000963956,0.0002966068,0.001542101,0.000287566,0.0004633532,0.0005575191,0.0002986114,0.001669889,0.0007786909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005734942,"about_ca_system_score_gemma":0.0008195076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004184938,"about_ca_topic_score_gemma":0.001812856,"domain_scores_codex":[0.999665,0.0001769501,0.00002212339,0.00005563177,0.00003311133,0.00004709077],"domain_scores_gemma":[0.9993737,0.0001092072,0.00020018,0.00003391343,0.00002541625,0.0002576606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8957846,0.006865756,0.01623266,0.00116089,0.002777309,0.0002863133,0.0001097173,0.001503628,0.0130836,0.000360537,0.008319049,0.05351597],"study_design_scores_gemma":[0.7319148,0.193416,0.06005494,0.0001177439,0.002849842,0.0007711375,0.00006252217,0.002062028,0.002124673,0.0006281134,0.005944188,0.0000541724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9844462,0.006082278,0.0004013586,0.0008484813,0.0001726366,0.001097192,0.002736906,0.00009356581,0.004121311],"genre_scores_gemma":[0.9921843,0.001135705,0.0005863684,0.001106446,0.0002185831,0.0005846341,0.002495372,0.00001263157,0.001675964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004560478,"threshold_uncertainty_score":0.01525629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04670689773874537,"score_gpt":0.4022140875305723,"score_spread":0.3555071897918269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}